Abrogating the induction of type 2 diabetes mellitus secondary to statin therapy

Cardiovasc Drugs Ther. 2014 Oct;28(5):393-4. doi: 10.1007/s10557-014-6551-8.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Diabetes Mellitus, Type 2 / chemically induced*
  • Fluorobenzenes / adverse effects*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Insulin Resistance / genetics*
  • PTEN Phosphohydrolase / biosynthesis*
  • Pyrimidines / adverse effects*
  • Rosuvastatin Calcium
  • Sulfonamides / adverse effects*
  • Up-Regulation / drug effects*

Substances

  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrimidines
  • Sulfonamides
  • Rosuvastatin Calcium
  • PTEN Phosphohydrolase
  • Pten protein, mouse